Dr. Cole's research focuses on discovering the cognitive and neural mechanisms that make human behavior uniquely flexible and intelligent. His research focuses on two broad themes. 1) Brain network mechanisms of flexible cognitive control: Flexible control – a capacity supporting adaptive, goal-directed behavior important in daily life – is affected in a variety of mental illnesses, markedly reducing quality of life. See Cole & Schneider (2007) for evidence that flexible control is implemented...
Assistant Professor of Psychiatry
Dr. Philip Robert Corlett trained in Experimental Psychology, Cognitive Neuroscience and Psychiatry with Professors Trevor Robbins and Paul Fletcher at the University of Cambridge. He won a Wellcome Trust Prize Studentship and completed his PhD on the brain bases of delusion formation in the Brain Mapping Unit, Department of Psychiatry. After a short postdoc, he was awarded the University of Cambridge Parke- Davis Exchange Fellowship in Biomedical Sciences which brought him to the Yale...
Professor of Psychiatry
The research focus of my laboratory is on the genetics of brain structure and function. Our goals include elucidation of the neurobiological roots of major mental illnesses through the integration of cognitive neuropsychological, functional and structural neuroimaging, and behavioral and molecular genetic approaches. The ultimate goals of this research is the identification of genes involved in affective and psychotic illnesses as well as genes that influence non-pathological brain structure...
Robert L. McNeil, Jr. Professor of Psychiatry and Professor of Neuroscience
Chair, Department of Psychiatry
Chief of Psychiatry, Yale-New Haven Hospital
Director: NIAAA Center for the Translational Neuroscience of Alcoholism
Director, Clinical Neuroscience Division, VA National Center for PTSD
Alcoholism; Drug Therapy; Genetics; Neurobiology; Psychiatry; Schizophrenia; Stress Disorders, Post-Traumatic; Veterans; Neuroimaging
Dr. Krystal is a leading expert in the areas of alcoholism, schizophrenia, and post-traumatic stress disorder. His work links psychopharmacology, neuroimaging, molecular genetics, and computational neuroscience to study the neurobiology and to develop novel treatments for these disorders. He is best known for leading the discovery of the rapid antidepressant effects of ketamine in depressed patients.
He is a member of the U.S. National Academy of Medicine. He also serves in a variety of advisory...
Associate Professor of Psychiatry
Associate Director, Cocaine Research Clinic
Medical Director, Forensic Drug Diversion Clinic
President, Medical and Professional Staff of Connecticut Mental Health Center
Behavior and Behavior Mechanisms; Sleep Disorders; Substance-Related Disorders
YCCI K Scholar
Project: 09/30/06 - 06/30/09
Sleep and cognition in cocaine dependece
Dr. John D. Murray is an Assistant Professor in the Department of Psychiatry. Dr. Murray trained in Physics and Mathematics at Yale University. For his PhD in Physics, he worked with Dr. Xiao-Jing Wang in the field of Computational Neuroscience. Following his graduate training, he was a Postdoctoral Associate at New York University in the Center for Neural Science. He joined the faculty at Yale in 2015, where he directs a computational neuroscience lab with interests in leveraging computational...
Professor of Psychiatry and of Neuroscience
Genotype; Magnetic Resonance Imaging; Neurobiology; Phenotype; Psychiatry; Psychotic Disorders; Substance-Related Disorders; Endophenotypes
Dr. Pearlson's medical training was in the University of Newcastle upon Tyne in England . Following this he completed a graduate degree in philosophy at Columbia University in New York and was successively a resident, postdoctoral fellow and faculty member at Johns Hopkins University Department of Psychiatry under Dr. Paul McHugh, where he was ultimately Professor of Psychiatry and founding director of the division of Psychiatry Neuroimaging.
Dr. Pearlson is currently founding director of the...
Associate Professor of Psychiatry and in the Child Study Center
Director, Yale OCD Research Clinic
Associate Director, Neuroscience Research Training Program
Basal Ganglia Diseases; Tourette Syndrome; Learning; Molecular Biology; Neuroanatomy; Neurobiology; Neurophysiology; Neurosciences; Obsessive-Compulsive Disorder; Phobic Disorders; Psychopharmacology; Trichotillomania
Christopher Pittenger earned his MD and Ph.D. degrees from Columbia University, where his graduate work was done with Nobel Prize recipient Eric Kandel. He returned to Yale University - where he had done his undergraduate studies - for residency and research training in psychiatry in 2003. He joined the faculty as an Assistant Professor in 2007 and was promoted to the rank of Associate Professor in 2013.
During his Ph.D. studies in basic neurobiology, he became fascinated by the brain's ability...
Dr. Grega Repovs graduated in Psychology at Department of Psychology, Faculty of Arts, University of Ljubljana in 1996. He was offered a position the same year as instructor in General psychology. In 1999 successfully completed masters thesis Semantic memory and visual attention in schizophrenia at Department of Psychology, Faculty of Arts, University of Ljubljana. In 2002 Successfuly defended Ph.D. dissertation titled: "Computational model of attentional deficits in schizophrenia". Dr. Repovs...
Associate Professor of Psychiatry
Associate Program Director, Psychiatry Residency Training
Director, STEP Program
Curriculum; Mental Health Services; Psychotic Disorders; Schizophrenic Psychology; Health Care Quality, Access, and Evaluation; Evidence-Based Medicine; Schizophrenia and Disorders with Psychotic Features
Dr. Srihari's clinical and research interests are focused on the evaluation and treatment of individuals with psychotic disorders. He directs a clinic that provides a specialized model of care to individuals who are early in the course of a psychotic disorder. The clinic for Specialized Treatment Early in Psychosis (STEP, www.step.yale.edu) is based at the Connecticut Mental Health Center, New Haven. In 2015, the program initiated a population health campaign to reduce the duration of untreated...